Pamrevlumab
Pamrevlumab (FG-3019) is a human antibody with affinity for connective tissue growth factor (CTGF) and is involved in anti-CTGF therapy for the treatment of idiopathic pulmonary fibrosis (IPF) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
CAS Number
946415-13-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1397978-01 0.02 mg (E-Coli)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details 
MBS1397978-02 0.02 mg (Yeast)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details 
MBS1397978-03 0.1 mg (E-Coli)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details MBS1397978-04 0.1 mg (Yeast)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details MBS1397978-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details MBS1397978-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli N-acetyl-D-glucosamine kinase (nagK)
Ask
View Details